SEC Form 4 · accession 0001387131-18-001515

Corindus Vascular Robotics, Inc. · CVRS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Apr 6, 2018

Accepted (ET)

Apr 10, 2018 · 5:55 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001528557

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Apr 6, 2018	A	653	$1.36	A	7,433	D
Common Stock^F2	holding	—	—		—	11,336,154	I	See Footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series A Preferred Stock^F2,F3	$1.25	holding	—	—	—	Mar 16, 2018	—	Common Stock	10,800,000	540,000	I
Warrant^F2	$1.40	holding	—	—	—	Sep 16, 2018	Mar 16, 2028	Common Stock	4,725,000	4,725,000	I

F1The 653 shares of Common Stock were issued to the reporting person pursuant to the Corindus Vascular Robotics, Inc. Director Compensation Policy in lieu of, at the reporting person's election, his pro-rated quarterly cash retainer and any meeting fees in the amount of $889.
F2Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), as the investment advisor to certain affiliated investment funds, and HEC Management GP LLC, a Delaware limited liability company ("Management GP"), as the general partner of Hudson Executive, may be deemed to be the beneficial owners of the securities. By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the securities reported for purposes of Rule 16a-1(a). Mr. Braunstein disclaims any beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein.
F3The preferred stock is perpetual and therefore has no expiration date.